The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 21, 2010
Filed:
Apr. 16, 2004
Heidi Ackerly, Belmont, CA (US);
Avi Ashkenazi, San Mateo, CA (US);
David Eberhard, San Francisco, CA (US);
Gretchen Frantz, San Francisco, CA (US);
Dorothy French, San Carlos, CA (US);
Germaine G. Fuh, Pacifica, CA (US);
Jo-anne S. Hongo, Redwood City, CA (US);
Chingwei V. Lee, Foster City, CA (US);
Scot A. Masters, San Carlos, CA (US);
Helga A. Raab, San Francisco, CA (US);
Evgeny Varfolomeev, Burlingame, CA (US);
Beni B. Wolf, Redwood City, CA (US);
Robert Maurice Pitti, El Cerrito, CA (US);
Liliana Soroceanu, San Francisco, CA (US);
Heidi Ackerly, Belmont, CA (US);
Avi Ashkenazi, San Mateo, CA (US);
David Eberhard, San Francisco, CA (US);
Gretchen Frantz, San Francisco, CA (US);
Dorothy French, San Carlos, CA (US);
Germaine G. Fuh, Pacifica, CA (US);
Jo-Anne S. Hongo, Redwood City, CA (US);
Chingwei V. Lee, Foster City, CA (US);
Scot A. Masters, San Carlos, CA (US);
Helga A. Raab, San Francisco, CA (US);
Evgeny Varfolomeev, Burlingame, CA (US);
Beni B. Wolf, Redwood City, CA (US);
Robert Maurice Pitti, El Cerrito, CA (US);
Liliana Soroceanu, San Francisco, CA (US);
Genentech, Inc., South San Francisco, CA (US);
Abstract
The present invention provides novel polypeptides, antibodies, antagonists, agonists, potentiators, nucleic acid molecules, compositions and methods relating to the STOP-1 polypeptide that are useful for treating and preventing diseases and for medical diagnosis and research. The present invention also provides consensus sequences and specific sequences for antibodies that specifically bind to STOP-1 that are useful in the methods described herein.